Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency
Author(s) -
Adda Grimberg,
Sara A. DiVall,
Constantin Polychronakos,
David B. Allen,
Laurie E. Cohen,
Jose Bernardo Quintos,
Wilma C. Rossi,
Chris Feudtner,
M. Hassan Murad
Publication year - 2016
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000452150
Subject(s) - idiopathic short stature , guideline , medicine , growth hormone deficiency , short stature , grading (engineering) , growth hormone , pediatrics , endocrine system , turner syndrome , intensive care medicine , endocrinology , hormone , pathology , civil engineering , engineering
On behalf of the Drug and Therapeutics, and Ethics Committees of the Pediatric Endocrine Society, we sought to update the guidelines published in 2003 on the use of growth hormone (GH). Because idiopathic short stature (ISS) remains a controversial indication, and diagnostic challenges often blur the distinction between ISS, GH deficiency (GHD), and primary IGF-I deficiency (PIGFD), we focused on these three diagnoses, thereby adding recombinant IGF-I therapy to the GH guidelines for the first time.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom